View in EDS HTML Full Text PDF Full Text

Public feedback to FDA on regulatory considerations for AI in drug manufacturing.

Saved in:
Bibliographic Details
Title: Public feedback to FDA on regulatory considerations for AI in drug manufacturing.
Authors: Das, Jayanti1 (AUTHOR), O'Connor, Thomas F.1 (AUTHOR), Fisher, Adam C.1 (AUTHOR), Osorio, Manuel2 (AUTHOR), Lam, Johnny2 (AUTHOR), Myers, Riley C.1 (AUTHOR) riley.myers@fda.hhs.gov
Source: AAPS Open. 5/5/2025, Vol. 11 Issue 1, p1-8. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:23649534
DOI:10.1186/s41120-025-00110-w